Other Clinical Trial - Neoadjuvant Envafolimab in Resectable & Locally

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05920928` - Comparison of the Clinical Response of Total Neoadjuvant Treatment of Two Methods of Long-term or Short-term Chemoradiotherapy in Rectal Cancer	N/A
Completed	`NCT06314737` - Assessment of Efficacy of Neoadjuvant Therapy in Locally Advanced Rectal Cancer
Recruiting	`NCT05524012` - Longitudinal Multimodal Response Assessment During Neoadjuvant Treatment of Rectal Cancer
Recruiting	`NCT05601505` - Circulating Tumor DNA-guided Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer	Phase 2
Recruiting	`NCT05876026` - MRI T1 Relaxation Time in Rectal Cancer
Completed	`NCT05622357` - Prospective Study of Short Course Radiation Therapy Followed by Neoadjuvant Chemotherapy and Surgery in Locally Advanced Rectal Cancer	Phase 2
Terminated	`NCT04406857` - Testing the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine) During Radiation Therapy for Rectal Cancer	Phase 1
Not yet recruiting	`NCT06292975` - Exercise for Improving Radiotherapy Efficacy in Rectal Cancer	N/A
Not yet recruiting	`NCT06276686` - Exercise for Improving Long-course Chemoradiotherapy Efficacy in People With Locally Advanced Rectal Cancer	N/A
Recruiting	`NCT05591534` - Endorectal Brachytherapy for Rectal Cancer	Phase 2
Recruiting	`NCT05722288` - Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers	Phase 2
Active, not recruiting	`NCT06314750` - Deep Learning Based MRI Radiomics in Predicting the Clinical Risk of Locally Advanced Rectal Cancer
Recruiting	`NCT05731726` - Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer	Phase 2
Recruiting	`NCT06312982` - A Series of Neoadjuvant Chemoradiotherapy Combined With Immunotherapy for Locally Advanced Rectal Cancer: From a Multicenter Phase II Cohort to a Phase III Randomized Controlled Study	Phase 2/Phase 3
Recruiting	`NCT04703101` - Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer	Phase 1
Recruiting	`NCT05610163` - Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation	Phase 2
Recruiting	`NCT05245786` - An Investigational Scan (64Cu-Labeled M5A Antibody) in Combination With SOC Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer	Early Phase 1
Terminated	`NCT03280277` - Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Locally Advanced Rectal Cancer	Early Phase 1
Recruiting	`NCT05772923` - Organ Preservation in Rectal Cancer: Contact X-ray Brachytherapy vs Extending the Waiting Interval and Local Excision	N/A
Recruiting	`NCT05792735` - Neoadjuvant Cadonilimab Plus Chemotherapy Following Short-Course Radiotherapy in Locally Advanced Rectal Cancer	Phase 2

NCT number	NCT05645094
Study type	Observational
Source	Fudan University
Contact	Yaqi Li, PhD
Phone	+8615902194450
Email	yaqili702@hotmail.com
Status	Not yet recruiting
Phase
Start date	January 1, 2023
Completion date	June 1, 2026

Neoadjuvant Envafolimab in Resectable and Locally Advanced MSI-H/dMMR Rectal Cancer

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms